# US 2008/0188791 A1 · Active iontophoresis delivery system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188791 A1
- Document ID: US20080188791A1
- Status: Published application
- Kind: A1
- Application number: 11/701,749
- Filed: 2007-02-02
- Published: 2008-08-07
- Earliest claimed: 2007-02-02
- Inventors: Attilio E. DiFiore; Jamal S. Yanaki
- Web page: https://patentgrep.com/patent/US20080188791A1

## CPC

- A61N 1/303: {Constructional details (electrodes for external use A61N1/0428)}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A fully integrated, independently accurately performing, active transdermal medicament patch includes a flexible substrate with an adhesive-coated therapeutic face carrying a medicament reservoir. A circuit non-removably carried on the substrate and driven by a light-weight power source causes a substantially constant current to flow for a predetermined therapy period through the reservoir and the skin against which the therapeutic face is disposed. Net electrical polarity of the medicament determines the interconnection of circuit and power source to skin. The circuit includes a field effect transistor or an operational amplifier with a zener diode or a voltage regulator. A timer non-removably carried on the substrate disables the circuit following functioning the therapy period. An active transdermal medicament delivery system employs a single patch or pair of patches physically and electrically connected by a distensible tether.

## Claims

### Claim 1

An active transdermal medicament patch comprising:
(a) a flexible, planar biocompatible substrate having a therapeutic face on one side thereof configured for disposition against the skin of a patient;
(b) a medicament reservoir positioned on said therapeutic face of said substrate, said reservoir electrically conductively engaging the skin of a patient when said therapeutic face of said substrate is disposed there against;
(c) a power source carried on said substrate;
(d) current means non-removably carried on said substrate and driven by said power source for causing a substantially constant current through said reservoir and the skin of a patient during the course of a predetermined therapy period; and
(e) control means non-removably carried on said substrate for disabling said current means following functioning of said current means for said therapy period.

### Claim 2 (depends on 1)

A medicament patch as recited in claim 1, wherein said therapeutic face of said substrate is configured for removable securement to the skin of a patient.

### Claim 3 (depends on 2)

A medicament patch as recited in claim 2, wherein said therapeutic face of said substrate is coated with a biocompatible adhesive.

### Claim 4 (depends on 3)

A medicament patch as recited in claim 3, further comprising a release liner covering said adhesive.

### Claim 5 (depends on 1)

A medicament patch as recited in claim 1, wherein said medicament reservoir is positioned interior of the periphery of said therapeutic face of said substrate.

### Claim 6 (depends on 1)

A medicament patch as recited in claim 1, further comprising an electrical contact positioned on said therapeutic face of said substrate electrically isolated from said reservoir, said contact being capable of electrically conductively engaging the skin of a patient when said therapeutic face of said substrate is disposed there against.

### Claim 7 (depends on 6)

A medicament patch as recited in claim 6, wherein said power source is electrically coupled between said current means and said electrical contact.

### Claim 8 (depends on 6)

A medicament patch as recited in claim 6, wherein said power source is electrically coupled between said current means and said medicament reservoir.

### Claim 9 (depends on 1)

A medicament patch as recited in claim 1, wherein said power source produces non-alternating power.

### Claim 10 (depends on 9)

A medicament patch as recited in claim 9, wherein said power source comprises a plurality of series-connected batteries.

### Claim 11 (depends on 9)

A medicament patch as recited in claim 9, wherein said power source comprises a direct current alternator.

### Claim 12 (depends on 1)

A medicament patch as recited in claim 1, wherein said control means is driven by said power source.

### Claim 13 (depends on 1)

A medicament patch as recited in claim 1, further comprising an auxiliary power source carried on said substrate, said control means being driven by said auxiliary power source.

### Claim 14 (depends on 1)

A medicament patch as recited in claim 1, wherein said control means comprises a timer.

### Claim 15 (depends on 1)

A medicament patch as recited in claim 1, further comprising indicator means non-removably carried on said substrate for signaling when said current means is functioning.

### Claim 16 (depends on 15)

A medicament patch as recited in claim 15, wherein said indicator means comprises a visual indicator.

### Claim 17 (depends on 16)

A medicament patch as recited in claim 16, wherein said visual indicator is a light-emitting diode.

### Claim 18 (depends on 17)

A medicament patch as recited in claim 17, wherein said light-emitting diode operates intermittently during said therapy period.

### Claim at position 19

19-27. (canceled)

### Claim 28 (depends on 1)

An active transdermal medicament patch as recited in claim 1, wherein said current means non-removably carried on said substrate and driven by said power source for delivering a substantially constant current through said reservoir and the skin of a patient during the course of a predetermined therapy period does so for a patient having a current flow skin resistance within a meaningful range of current flow skin resistances.

### Claim 29 (depends on 28)

A medicament patch as recited in claim 28, wherein said meaningful range of current flow skin resistances comprises current flow skin resistances in a range of from about 20 kilo-ohms to about 70 kilo-ohms.

### Claim 30 (depends on 29)

A medicament patch as recited in claim 29, wherein said meaningful range of current flow skin resistances comprises current flow skin resistances in a range of from about 25 kilo-ohms to about 50 kilo-ohms.

### Claim 31 (depends on 30)

A medicament patch as recited in claim 30, wherein said meaningful range of current flow skin resistances comprises current flow skin resistances in a range of from about 30 kilo-ohms to about 40 kilo-ohms.

### Claim 32 (depends on 30)

A medicament patch as recited in claim 30, wherein variation in said substantially constant current is limited by said current means to plus or minus 5% of a target therapeutic current flow.

### Claim 33 (depends on 32)

A medicament patch as recited in claim 32, wherein said target therapeutic current flow is equal to about 230 milliamperes.

### Claim 34 (depends on 32)

A medicament patch as recited in claim 32, wherein variation in said substantially constant current is limited by said current means to plus or minus 2% of a target therapeutic current flow.

### Claim 35 (depends on 34)

A medicament patch as recited in claim 34, wherein said target therapeutic current flow is equal to about 230 milliamperes.

### Claim 36 (depends on 28)

A medicament patch as recited in claim 28, wherein at the commencement of said therapy period, the output of said power source is direct current at an electromotive force in a range of from about 9 volts to about 18 volts.

### Claim 37 (depends on 36)

A medicament patch as recited in claim 36, wherein said power source comprises a plurality of series-connected batteries.

### Claim 38 (depends on 36)

A medicament patch as recited in claim 36, wherein at the commencement of said therapy period, the output of said power source is direct current at an electromotive force of about 12 volts

### Claim 39 (depends on 38)

A medicament patch as recited in claim 38, wherein said power source comprises a plurality of series-connected batteries.

### Claim 40 (depends on 28)

A medicament patch as recited in claim 28, wherein the duration of said therapy period is in a range of from about 5 hours to about 8 hours.

### Claim 41 (depends on 40)

A medicament patch as recited in claim 40, wherein the duration of said therapy period is about 7 hours.

### Claim 42 (depends on 28)

A medicament patch as recited in claim 28, further comprising indicator means non-removably carried on said substrate for signaling when said current means is functioning.

### Claim 43 (depends on 28)

A medicament patch as recited in claim 28, further comprising a supplementary power source carried on said substrate dedicated to delivering power to said control means.

### Claim 44 (depends on 43)

A medicament patch as recited in claim 43, further comprising indicator means non-removably carried on said substrate for signaling when said current means is functioning, said indicator means being driven by said supplementary power source.

### Claim 45 (depends on 28)

A medicament patch as recited in claim 28, wherein said power source, said reservoir, and said current means are so interconnected as to enable said medicament patch to deliver into the skin of a patient a positive polarity medicament disposed in said reservoir.

### Claim 46 (depends on 28)

A medicament patch as recited in claim 28, wherein said power source, said reservoir, and said current means are so interconnected as to enable said medicament patch to deliver into the skin of a patient a negative polarity medicament disposed in said reservoir.

### Claim 47 (depends on 1)

An active transdermal medicament patch as recited in claim 1, wherein said current means comprises an electric circuit non-removably carried on said substrate, said electric circuit being driven by said power source and being series-connected with said reservoir and the skin of a patient, said electrical circuit thereby delivering through said reservoir and the skin of a patient a substantially constant current of about 230 plus or minus 10 milliamps during the course of a predetermined therapy period for a patient having a current flow skin resistance within a meaningful range of current flow skin resistances from about 20 kilo-ohms to about 70 kilo-ohms.

### Claim 48 (depends on 47)

A medicament patch as recited in claim 47, further comprising control means non-removably carried on said substrate for disabling said electric circuit following functioning of said electric circuit for said therapy period.

### Claim 49 (depends on 48)

A medicament patch as recited in claim 48, wherein said control means comprises a timer.

### Claim 50 (depends on 49)

A medicament patch as recited in claim 49, wherein said timer comprises a flip-flop down-counter.

### Claim 51 (depends on 49)

A medicament patch as recited in claim 49, wherein said timer is coupled to the gate of a transistor source-to-drain series-connected between said electric circuit and said power source.

### Claim 52 (depends on 51)

A medicament patch as recited in claim 51, wherein said timer is driven by a tap from said power source.

### Claim 53 (depends on 51)

A medicament patch as recited in claim 51, wherein said timer is driven by a supplemental power source.

### Claim 54 (depends on 52)

A medicament patch as recited in claim 52, wherein said supplemental power source comprises a three-volt battery.

### Claim 55 (depends on 47)

A medicament patch as recited in claim 47, wherein at the commencement of said therapy period, said power source delivers direct current at an electromotive force in a range of from about 9 volts to about 18 volts.

### Claim 56 (depends on 47)

A medicament patch as recited in claim 47, wherein said electric circuit is coupled through said reservoir to the skin of a patient.

### Claim 57 (depends on 47)

A medicament patch as recited in claim 47, wherein said electric circuit is coupled through the skin of a patient to said reservoir.

### Claim 58 (depends on 57)

A medicament patch as recited in claim 57, wherein said electric circuit comprises a field effect transistor source-to-drain series-connected between said power source and the skin of a patient.

### Claim 59 (depends on 58)

A medicament patch as recited in claim 58, wherein the gate of said field effect transistor is coupled through a tuning resistor to said power source.

### Claim 60

(canceled)

### Claim 61 (depends on 47)

A medicament patch as recited in claim 47, wherein said electric circuit comprises:
(a) an operational amplifier; and
(b) amplifier output current stabilization means for maintaining the delivery of said substantially constant current by said operational amplifier through said reservoir and the skin of a patient.

### Claim at position 54

62-69. (canceled)

### Claim 70

An active transdermal medicament patch comprising:
(a) a flexible, planar biocompatible substrate having a therapeutic face on one side thereof configured for disposition against the skin of a patient:
(b) a medicament reservoir positioned on said therapeutic face of said substrate said reservoir electrically conductively enaaging the skin of a patient when said therapeutic face of said substrate is disposed there against;
(c) a power source carried on said substrate; and
(d) an electric circuit non-removably carried on said substrate, said electric circuit being driven by said power source and being series-connected with said reservoir and the skin of a patient when said therapeutic face of said substrate is disposed there against, said electrical circuit thereby delivering a substantially constant current through said reservoir and the skin of the patient.

### Claim 71 (depends on 70)

A medicament patch as recited in claim 70, wherein said electric circuit is coupled through said reservoir to the skin of a patient.

### Claim 72 (depends on 70)

A medicament patch as recited in claim 70, wherein said electric circuit is coupled through the skin of a patient to said reservoir.

### Claim 73 (depends on 71)

A medicament patch as recited in claim 71, wherein said electric circuit comprises a field effect transistor source-to-drain series-connected between said power source and the skin of a patient.

### Claim 74 (depends on 73)

A medicament patch as recited in claim 73, wherein the gate of said field effect transistor is coupled through a tuning resistor to said power source.

### Claim 75 (depends on 73)

A medicament patch as recited in claim 73, wherein the gate of said field effect transistor is coupled to a dedicated power source.

### Claim 76 (depends on 70)

A medicament patch as recited in claim 70, wherein said electric circuit comprises:
(a) an operational amplifier; and
(b) amplifier output current stabilization means for maintaining the delivery of said substantially constant current by said operational amplifier through said reservoir and the skin of a patient.

### Claim 77 (depends on 72)

A medicament patch as recited in claim 72, wherein said electric circuit comprises:
(a) an operational amplifier; and
(b) amplifier output current stabilization means for maintaining the delivery of said substantially constant current by said operational amplifier through said reservoir and the skin of a patient.

### Claim 78 (depends on 77)

A medicament patch as recited in claim 77, wherein said output current stabilization means comprises a feedback loop between a negative input terminal of said operational amplifier and said medicament reservoir.

### Claim 79 (depends on 78)

A medicament patch as recited in claim 78, wherein said feedback loop comprises a branch of a voltage divider coupling the ground for said electric circuit to said medicament reservoir.

### Claim 80 (depends on 79)

A medicament patch as recited in claim 79, wherein said electric circuit further comprises voltage reference means for providing a substantially invariant voltage to a positive input terminal of said operational amplifier.

### Claim 81 (depends on 80)

A medicament patch as recited in claim 80, wherein said voltage reference means comprises:
(a) a zener diode coupled between said positive input terminal of said operational amplifier and a ground for said electric circuit; and
(b) a bias resistor coupled between said power source and said positive input terminal of said operational amplifier.

### Claim 82 (depends on 80)

A medicament patch as recited in claim 80, wherein said electric circuit further compnses:
(a) a voltage regulator coupled between said power source and said positive input terminal of said operational amplifier; and
(b) regulator output voltage stabilization means for maintaining the delivery of a substantially constant voltage by said voltage regulator to said positive input terminal of said operational amplifier.

### Claim 83 (depends on 82)

A medicament patch as recited in claim 82, wherein said regulator output voltage stabilization means comprises a feedback loop between said positive input terminal of said operational amplifier and an auxiliary input terminal of said voltage regulator.

### Claim 84 (depends on 83)

A medicament patch as recited in claim 83, wherein said feedback loop comprises:
(a) a feedback resistor coupled between the output terminal of said voltage regulator and said positive input terminal of said operational amplifier; and
(b) a feedback signal line coupled between said positive input terminal of said operational amplifier and said auxiliary input terminal of said voltage regulator.
